Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Total 13F shares
-
6,319,783
-
Share change
-
-782,440
-
Total reported value
-
$285,412,733
-
Put/Call ratio
-
83%
-
Price per share
-
$45.12
-
Number of holders
-
119
-
Value change
-
-$30,450,968
-
Number of buys
-
61
-
Number of sells
-
56
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q4 2015
As of 31 Dec 2015,
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,319,783 shares.
The largest 10 holders included
Consonance Capital Management LP, BlackRock Fund Advisors, SENZAR ASSET MANAGEMENT, LLC, STATE STREET CORP, VANGUARD GROUP INC, Healthcare Value Capital, LLC, DEUTSCHE BANK AG\, BlackRock Institutional Trust Company, N.A., Allianz Asset Management AG, and NOMURA HOLDINGS INC.
This page lists
119
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.